首页> 外国专利> THERAPEUTIC AGENT FOR MENIERE DISEASE COMPRISING NEW BENZAZEPINE DERIVATIVE OR ITS SALT AS ACTIVE INGREDIENT

THERAPEUTIC AGENT FOR MENIERE DISEASE COMPRISING NEW BENZAZEPINE DERIVATIVE OR ITS SALT AS ACTIVE INGREDIENT

机译:包含新的苯扎西汀衍生物或其盐作为有效成分的重大疾病的治疗剂

摘要

PROBLEM TO BE SOLVED: To obtain an excellent therapeutic agent against Meniere disease, Meniere syndrome, dizziness, hearing disability or ringing in the ears. ;SOLUTION: The medicine comprises a new 1,4,5,6-tetrahydroimidazo[4,5- d]benzazepine derivative represented by general formula (ring D is a phenylene or pyridinediyl; X and Y are the same or different and are each CH or N; R1, R2 and R3 are the same as or different from each other and are each a hydrogen atom, a hydroxy group, a halogen or a lower alkyl) or its pharmaceutically permissible salt as active ingredient.;COPYRIGHT: (C)2004,JPO
机译:要解决的问题:要获得出色的抗美尼尔氏病,美尼尔氏综合症,头昏眼花,听力障碍或耳鸣的治疗剂。 ;解决方案:该药物包含一种新的由通式表示的1,4,5,6-四氢咪唑并[4,5-d]苯并ze庚因衍生物(环D为亚苯基或吡啶二基; X和Y相同或不同,分别是CH或N; R 1 ,R 2 和R 3 彼此相同或不同,分别为氢原子,羟基,卤素或低级烷基)或其药学上允许的盐为有效成分。;版权:(C)2004,JPO

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号